Oramed Pharma (ORMP) Issues Letter to Shareholders

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/17/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. TECHM:IN
10. NVDA

Go back to Oramed Pharma (ORMP) Issues Letter to Shareholders

Oramed Pharmaceuticals Issues Letter to Shareholders

March 4, 2025 9:00 AM EST

Key Highlights expected completion in YR 2025:

OraTech Pharmaceuticals Inc. - A new joint venture focused on oral insulin development, with planned U.S. Phase 3 trials.Distribution of majority of Oramed's holding in OraTech to Oramed shareholders via dividend planned to coincide with OraTech's public listing.Cash dividend planned (~$0.25 per share).Marketing Authorization Application has been submitted by HTIT, and... More